PBM

Propel Bio Management Portfolio holdings

AUM $117M
1-Year Est. Return 64.07%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+64.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$82.4M
AUM Growth
-$3.68M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
20
New
Increased
Reduced
Closed

Top Buys

1
+$10.5M
2
+$1.99M
3
+$739K
4
DCTH icon
Delcath Systems
DCTH
+$676K
5
MIST icon
Milestone Pharmaceuticals
MIST
+$453K

Top Sells

1
+$9.95M
2
+$5.27M
3
+$2.25M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$1.17M
5
CMPX icon
Compass Therapeutics
CMPX
+$434K

Sector Composition

1 Healthcare 69.43%
2 Energy 30.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$24.7M 30.01%
1,272,360
2
$13.9M 16.88%
6,153,091
+3,699,999
3
$12.2M 14.82%
228,884
4
$8.85M 10.74%
922,927
-212,000
5
$5.53M 6.71%
974,022
+350,000
6
$3.51M 4.26%
11,285,420
7
$3.48M 4.22%
1,791,557
+340,000
8
$3.07M 3.73%
226,052
+48,452
9
$3.03M 3.67%
2,087,139
10
$2.04M 2.48%
231,874
+52,000
11
$695K 0.84%
+70,000
12
$451K 0.55%
149,279
13
$423K 0.51%
146,381
14
– –
-228,317
15
– –
-30,032
16
– –
-178,500
17
– –
-183,259